Clinical Trials · NCT00771888

Open-Label Extension of LOCKCYST Trial

UnknownPhase 2/Phase 3Lanreotide (Unclear)
Phase
Phase 2/Phase 3
Recruitment status
Unknown
Sponsor
Radboud University Medical Center
Enrollment
54
Start date
Apr 2008
Locations
2 sites, Belgium, Netherlands
Primary endpoint
Liver volume reduction
View Lanreotide compound reference